Title : Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells.

Pub. Date : 2018 Apr

PMID : 29436642






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor-positive, human epidermal growth factor receptor 2-positive breast cancer cells. ruxolitinib erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 The results of the present study demonstrated the synergistic anticancer effects of ruxolitinib and calcitriol in ER and HER2-positive MCF7-HER18 breast cancer cells. ruxolitinib erb-b2 receptor tyrosine kinase 2 Homo sapiens